Living Donor Lung Transplantation for Pleuroparenchymal Fibroelastosis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 27106430.
- Also identified by DOI 10.1016/j.athoracsur.2015.07.056.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report the first patient with pleuroparenchymal fibroelastosis (PPFE) to undergo living donor bilateral lobar lung transplantation. The patient was diagnosed with secondary PPFE as a late complication of chemotherapy that included high-dose cyclophosphamide for mature B-cell lymphocytic leukemia. Although the patient maintained complete remission, dry cough and back pain appeared 8 years after the chemotherapy. He had repeated bilateral pneumothoraces, and his respiratory condition gradually deteriorated because of progressive pleural thickening and parenchymal fibrosis. He underwent living-donor bilateral lobar lung transplantation with an inverse transplant on the left side.
Medical subject headings
- Antineoplastic Agents
- Leukemia, B-Cell
- Living Donors
- Lung Transplantation
- Pleural Diseases
- Pulmonary Fibrosis